Javier Glez‐Vaz
0000-0001-8936-190X
Publication & Citation Trends
Publications
0 total
Human T cells engineered with an HLA-A2-restricted murine T-cell receptor targeting glypican 3 effectively control human hepatocellular carcinoma in mice OA
Cited by 3
Semantic Scholar
CD137 (4-1BB) and T-Lymphocyte Exhaustion.
Cited by 1
Semantic Scholar
mRNAs encoding IL-12 and a decoy-resistant variant of IL-18 synergize to engineer T cells for efficacious intratumoral adoptive immunotherapy OA
Cited by 34
Semantic Scholar
Intratumoral neoadjuvant immunotherapy based on the BO-112 viral RNA mimetic OA
Cited by 9
Semantic Scholar
Intratumoral immunotherapy with mRNAs encoding chimeric protein constructs encompassing IL-12, CD137 agonists, and TGF-β antagonists OA
Cited by 6
Semantic Scholar
Cytotoxicity as a form of immunogenic cell death leading to efficient tumor antigen cross‐priming OA
Cited by 15
Semantic Scholar
CD137 (4-1BB) requires physically associated cIAPs for signal transduction and antitumor effects OA
Cited by 5
Semantic Scholar
Synergistic effects of combined immunotherapy strategies in a model of multifocal hepatocellular carcinoma OA
Cited by 16
Semantic Scholar
Research Topics
CAR-T cell therapy research
(19)
Immunotherapy and Immune Responses
(17)
Immune Cell Function and Interaction
(11)
Cancer Immunotherapy and Biomarkers
(10)
Immune cells in cancer
(7)
Affiliations
University of California, Los Angeles
Navarre Institute of Health Research
Bipar
Clinica Universidad de Navarra
Centro de Investigación Biomédica en Red de Cáncer